Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ·Healthcare·Biotechnology
$31.14
+0.29%
Mkt Cap $1.85B
Analyst Ratings
Buy
7
Hold
2
Sell
1
Price Target (19 analysts)
$48.17
Range $31.00 – $62.00
Implied Upside
+54.7%
Consensus $48.17 vs current $31.14